You're right, Aromasin is indicated for use after Tamoxifen treatments. Novartis/Femara and Astra/Arimidex are indicated for 1st line treatment of postmenopausal women with ER+ BC. So they could have used either from this aspect. I can think of why Femara over Arimidex too.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.